Гематология
2211 статей · 38 журналов
Журналы подкатегории (38)
- Annals of Hematology · Springer Nature (468)
- Blood Research · Springer Nature (143)
- Annals of Thoracic Surgery Short Reports · Elsevier (114)
- Journal of Thrombosis and Haemostasis · Elsevier (110)
- Blood Advances · Elsevier (101)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (99)
- British Journal of Haematology · Wiley (90)
- Blood · Elsevier (85)
- Thrombosis Research · Elsevier (82)
- Vox Sanguinis · Wiley (80)
- European Journal of Haematology · Wiley (79)
- Haemophilia · Wiley (73)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (71)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (66)
- Annals of Oncology · Elsevier (64)
- Transfusion · Wiley (64)
- American Journal of Hematology · Wiley (58)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- Seminars in Oncology · Elsevier (29)
- The Lancet Haematology · Elsevier (28)
- Transfusion Medicine · Wiley (28)
- Experimental Hematology · Elsevier (22)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (15)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (7)
- Leukemia · Springer Nature (7)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
-
Checkpoint inhibitor–induced hematologic immune-related adverse events and their association with disease recurrence in hematolymphoid malignancies: a clinical perspective
Abstract Immune checkpoint inhibitors have transformed the treatment of hematolymphoid malignancies by enhancing antitumor immunity. These agents are associated with immune-related adverse events (irAEs), including hematologic...
-
Prognostic significance of PNH clones in aplastic anemia treated with immunosuppression or allogeneic HSCT: a 20-year single-center experience
Abstract Background Paroxysmal nocturnal hemoglobinuria (PNH) clones are detected in up to 60% of patients with aplastic anemia (AA); however, their prognostic impact remains incompletely defined, particularly in the context of...
-
Monitoring of JAK2V617F allele burden in patients with essential thrombocythemia
Abstract Background/Aim This study retrospectively examined the clinical implications of monitoring JAK2 V617F, with a particular focus on disease transformation, in a Korean population of patients with essential thrombocythemia (ET)....
-
Targeting the HERV-K102 envelope elicits pyroptosis and represents a novel therapeutic strategy for acute myeloid leukemia
Abstract Objective Several recent studies have focused on human endogenous retroviruses (HERVs). HERVs entered the human genome millions of years ago and are associated with various diseases including cancer and immune regulation. Among...
-
Autologous bone marrow transplantation in non-Hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental study
Abstract Purpose Non-Hodgkin lymphoma (NHL) constitutes 90% of all lymphomas and accounts for 2.8% of new cancer cases and 2.6% of cancer-related deaths in 2020. Hematopoietic stem cell transplantation remains the standard treatment for...
-
Comparative evaluation of two NGS-based assays for somatic hypermutation analysis of IGHV genes in chronic lymphocytic leukemia
Abstract Purpose Somatic hypermutation (SHM) of the immunoglobulin heavy chain variable ( IGHV ) region is a key prognostic marker in chronic lymphocytic leukemia (CLL). Traditionally, SHM status has been determined using Sanger...
-
Letermovir for cytomegalovirus prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation: a single-center experience
Abstract Purpose Letermovir prophylaxis results in a significantly lower risk of clinically significant cytomegalovirus (CMV) infection in adult hematopoietic stem cell transplant recipients. However, studies supporting its efficacy in...
-
Epstein–Barr virus-associated lymphoma: current understanding and treatment strategies
Abstract Epstein–Barr virus (EBV) infection is well-known for its high prevalence rate, association with several diseases including cancer and autoimmune conditions, and a wide variety of symptoms and prognosis. When acquired at a young...
-
Rapidly progressive varicella zoster virus vasculopathy in a chemotherapy- and steroid-immunosuppressed patient with refractory diffuse large B-cell lymphoma: diagnostic and therapeutic challenges
Abstract Varicella zoster virus (VZV) vasculopathy is a rare but severe neurological complication that frequently results in a reversible cerebral vasoconstriction syndrome (RCVS). Diagnosis is often delayed because early manifestations...
-
Discordance between immunofixation and free light chain assays in multiple myeloma: a retrospective analysis and evaluation of the heavy/light chain assay for disease monitoring
Abstract Background Accurate detection and monitoring of monoclonal proteins in multiple myeloma (MM) are critical for diagnosis and treatment guidance. Conventional assays such as serum protein electrophoresis (SPEP), immunofixation...
- Systemic multiple thrombosis caused by double homozygous mutations of PAI-1 4G/4G and MTHFR C677T during pregnancy
- Macrophage polarization in hematologic cancers: mechanisms and therapeutic strategies
-
Hypermethylation-mediated silencing of RASD1 drives multiple myeloma pathogenesis
Abstract Background The role of Ras-related dexamethasone-induced 1 (RASD1) in multiple myeloma (MM) pathogenesis remains unclear. This study investigated the expression profile, clinical significance, and epigenetic regulation of RASD1...
-
The role of m6A RNA methyltransferase METTL3 in drug resistance mechanisms in acute myeloid leukemia
Abstract This review examines the role of METTL3, a core RNA methyltransferase, in therapeutic resistance in acute myeloid leukemia (AML) and discusses emerging strategies to address this challenge. METTL3 regulates N 6 -methyladenosine...
-
Propensity score analysis using the freely available user-friendly software EZR (Easy R)
Abstract EZR (Easy R) is a statistical software package that is freely available on our website ( https://www.jichi.ac.jp/usr/hema/EZR/statmed.html ) and can be used on both Windows (Microsoft Corporation, USA) and macOS (Apple, USA)...
- Prognostic impact of smoking and alcohol consumption in male patients with diffuse large B-cell lymphoma: a multicenter retrospective study
- STING-Dependent spontaneous platelet adhesion potentiates NK cell proinflammatory responses in pediatric crohn’s disease
-
Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes
Abstract Purpose Myelodysplastic syndromes/neoplasms (MDS) represent a heterogeneous group of clonal hematopoietic disorders with variable prognosis. While several risk models exist, the prognostic role of immune-related biomarkers...
- Awareness and real-world practices in chronic lymphocytic leukemia: insights from a nationwide survey of Korean hematologists
- Prophylactic donor lymphocyte infusions after first allogeneic hematopoietic stem cell transplantation in children with acute leukemia
- Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches
- Measurable residual disease monitoring after hematopoietic stem cell transplantation
- Insights into Treatment-Free Remission (TFR) outcomes in Chronic Myeloid Leukaemia (CML) – a tertiary centre experience in Malaysia
- Invasive fungal infections in hematologic diseases: evidence, challenges, and clinical practice
- Plasma interleukin-12 levels as a potential biomarker of fatigue and quality of life in patients with primary immune thrombocytopenia
-
Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant-eligible Korean patients with relapsed or refractory Hodgkin’s lymphoma
Abstract Purpose Brentuximab vedotin (BV)-based combinations have shown promising results in patients with relapsed or refractory Hodgkin’s lymphoma (RRHL) in Western countries. We conducted a phase II study to further define the role...
- A comparative study of hematologic response to ropeginterferon alfa-2b in hydroxyurea-resistant or intolerant polycythemia vera: a real-world data-based analysis
- Current immunotherapeutic approaches for relapsed/refractory follicular lymphoma: bispecific antibodies and CAR T-Cell therapies
- Durable responses and favorable cost-effectiveness of rituximab-based chemoimmunotherapy for primary cold agglutinin disease
- Beyond anemia: unraveling neutrophil defects and infection susceptibility in β-Thalassemia